IL124730A - Compositions for the treatment of gastrointestinal disorders comprising a bismuth compound and one or more antimicrobials, and the use of bismuth and an antimicrobial compound for the preparation of such compositions - Google Patents

Compositions for the treatment of gastrointestinal disorders comprising a bismuth compound and one or more antimicrobials, and the use of bismuth and an antimicrobial compound for the preparation of such compositions

Info

Publication number
IL124730A
IL124730A IL12473096A IL12473096A IL124730A IL 124730 A IL124730 A IL 124730A IL 12473096 A IL12473096 A IL 12473096A IL 12473096 A IL12473096 A IL 12473096A IL 124730 A IL124730 A IL 124730A
Authority
IL
Israel
Prior art keywords
bismuth
compositions
compound
antimicrobials
treatment
Prior art date
Application number
IL12473096A
Other languages
English (en)
Other versions
IL124730A0 (en
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of IL124730A0 publication Critical patent/IL124730A0/xx
Publication of IL124730A publication Critical patent/IL124730A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/245—Bismuth; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL12473096A 1995-12-07 1996-11-22 Compositions for the treatment of gastrointestinal disorders comprising a bismuth compound and one or more antimicrobials, and the use of bismuth and an antimicrobial compound for the preparation of such compositions IL124730A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/569,033 US6051604A (en) 1995-12-07 1995-12-07 Methods and compositions for the prevention and treatment of gastrointestinal disorders
PCT/US1996/018654 WO1997020567A1 (fr) 1995-12-07 1996-11-22 Compositions destinees a la prevention et au traitement de troubles gastro-intestinaux et comprenant du bismuth ainsi qu'un ou plusieurs agents antimicrobiens

Publications (2)

Publication Number Publication Date
IL124730A0 IL124730A0 (en) 1999-01-26
IL124730A true IL124730A (en) 2003-07-31

Family

ID=24273820

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12473096A IL124730A (en) 1995-12-07 1996-11-22 Compositions for the treatment of gastrointestinal disorders comprising a bismuth compound and one or more antimicrobials, and the use of bismuth and an antimicrobial compound for the preparation of such compositions

Country Status (18)

Country Link
US (1) US6051604A (fr)
EP (1) EP0865286B1 (fr)
AT (1) ATE212229T1 (fr)
BR (1) BR9611912A (fr)
CA (1) CA2239420C (fr)
CO (1) CO4790098A1 (fr)
DE (1) DE69618813T2 (fr)
DK (1) DK0865286T3 (fr)
ES (1) ES2166912T3 (fr)
IL (1) IL124730A (fr)
MX (1) MX9804578A (fr)
MY (1) MY127662A (fr)
NO (1) NO982634L (fr)
PE (1) PE37498A1 (fr)
PT (1) PT865286E (fr)
TR (1) TR199801022T2 (fr)
TW (1) TW586927B (fr)
WO (1) WO1997020567A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6429211B1 (en) * 2000-05-23 2002-08-06 Bayer Corporation Praziquantel compounds for treating diseases due to Sarcocystis Neospora Toxoplasma and Isospora
EP2408771B1 (fr) 2009-03-17 2016-11-16 Concert Pharmaceuticals, Inc. Composés de pyrazinoisoquinoline
EP4178558A1 (fr) * 2020-06-08 2023-05-17 Elevaid Therapeutics, Inc. Utilisation d'atovaquone et de proguanil pour le traitement de maladies gastro-intestinales et de l'inflammation

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR962163A (fr) * 1950-06-02
US4049817A (en) * 1972-08-14 1977-09-20 Sandoz Ltd. Synergistic compositions
US4514421A (en) * 1979-08-30 1985-04-30 Herschler R J Dietary and pharmaceutical uses of methylsulfonylmethane and compositions comprising it
WO1986005981A1 (fr) * 1985-04-18 1986-10-23 Borody Thomas J Traitement de la dyspepsie non ulcereuse avec des sels de bismuth
US5256684A (en) * 1985-06-13 1993-10-26 The Procter & Gamble Company Methods and compositions for the treatment of gastrointestinal disorders
ATE318144T1 (de) * 1985-06-13 2006-03-15 Barry James Marshall Pharmazeutische zusammensetzung zur behandlung gastrointestinaler beschwerden, die wismut und ein antimikrobielles mittel enthält
JPS63174926A (ja) * 1987-01-09 1988-07-19 Nitto Kasei Kk 家禽用抗コクシジウム剤
EP0439453B1 (fr) * 1987-10-12 1994-01-19 Exomed Australia Pty. Ltd. (ACN 051 976 446) Procede ameliore servant au traitement de troubles gastrointestinaux
EP0375068A1 (fr) * 1988-12-23 1990-06-27 Gist-Brocades N.V. Associations de composés de bismuth et de tétracyclines
US5221664A (en) * 1990-04-23 1993-06-22 Magainin Pharmaaceuticals Inc. Composition and treatment with biologically active peptides and toxic cations
WO1992001457A1 (fr) * 1990-07-20 1992-02-06 Slagel, David Produits et procedes de traitement des voies alimentaires
ATE184198T1 (de) * 1993-05-11 1999-09-15 Spirig Ag Festes bismut- und amoxycillinhaltiges arzneipräparat und seine verwendung
AUPM596894A0 (en) * 1994-05-30 1994-06-23 Hybrid Scientific Pty Ltd Composition for treating gastrointestinal disorders - a combination of bismuth salts plus lactobacillus or bifidobacteria species bacteria for treating gastrointestinal disorders

Also Published As

Publication number Publication date
EP0865286A1 (fr) 1998-09-23
PT865286E (pt) 2002-06-28
NO982634D0 (no) 1998-06-08
ATE212229T1 (de) 2002-02-15
DE69618813D1 (de) 2002-03-14
DK0865286T3 (da) 2002-03-25
CA2239420C (fr) 2003-03-18
PE37498A1 (es) 1998-08-27
TW586927B (en) 2004-05-11
MX9804578A (es) 1998-10-31
ES2166912T3 (es) 2002-05-01
CA2239420A1 (fr) 1997-06-12
MY127662A (en) 2006-12-29
NO982634L (no) 1998-08-04
IL124730A0 (en) 1999-01-26
EP0865286B1 (fr) 2002-01-23
BR9611912A (pt) 1999-04-06
DE69618813T2 (de) 2002-10-02
TR199801022T2 (xx) 1998-10-21
CO4790098A1 (es) 1999-05-31
US6051604A (en) 2000-04-18
WO1997020567A1 (fr) 1997-06-12

Similar Documents

Publication Publication Date Title
BG102667A (en) Diosgenine-containing composition
IL124730A (en) Compositions for the treatment of gastrointestinal disorders comprising a bismuth compound and one or more antimicrobials, and the use of bismuth and an antimicrobial compound for the preparation of such compositions
MX9804577A (es) Composiciones que contienen bismuto y uno o mas antimicrobianos, para la prevencion y tratamiento de trastornos gastrointestinales.
MX9804579A (es) Composiciones que contienen bismuto para la prevencion y tratamiento de trastornos gastrointestinales.
MX9804576A (es) Composiciones que contienen bismuto, para la prevencion y tratamiento de trastornos gastrointestinales.

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees